PHARMACEUTICAL STUDY OF APATYAKARAM GHRITA.
APPA Conference
Article
Certificate

Keywords

Apatyakaram Ghrita, Pharmaceutical study, Geriatric health problems, Anti-osteoporosis, Anti -arthritis, Cognitive health, malnourishment.

How to Cite

Kamble, V. V. (2018). PHARMACEUTICAL STUDY OF APATYAKARAM GHRITA. Ayurlog: National Journal of Research in Ayurved Science, 6(06). Retrieved from https://ayurlog.com/index.php/ayurlog/article/view/223

Abstract

Apatyakaram ghrita is a classical formulation stated in chapter pumanjat baladik vajikaran pad in text of charak samhita. Prepared with decoction of Shatavari, Vidari kanda, Maash, Atmagupta, Shwadanshtra , kalka of same drug, Go-dugdha, Go-ghrita. Individual ingredients of this formulation have aphrodisiac, rasayan, medhya etc properties. Rasayan is the formulation which promotes physical and mental health, helps to increase body’s capacity to overcome diseases and gives bala to the sharir and mana and increases satva guna, Aim: Preparation and standardization of Apatyakaram ghrita with special reference to Charak Samhita, Objective: 1. Authentication and standardization of raw material.2. Preparation of Apatyakaram Ghrita as described in Charak Samhita.3. To analyze the study drug physico-chemically to develop its standard, study deals with physicochemical analysis and standardization of the formulation, it can be inferred that Apatyakaram Ghrita may be effective in osteoporosis, osteoarthritis, cognitive impairment and malnourishment in elderly people.

Article
Certificate

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurlog.com and online filled (uploaded) form

 
 
 
 

Downloads

Download data is not yet available.